Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Bergmann

Showing results (171-180 of 175) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 175 results.
Translational Oncology|September 1, 2024
Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic responseJingyu An, Roma Kurilov, Teresa Peccerella, et al.
Cancer Cell|April 7, 2015
Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasisSilvia von Karstedt, Annalisa Conti, Max Nobis, et al.
Cancer Discovery|May 27, 2018
<i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic CancerChristoph Heining, Peter Horak, Sebastian Uhrig, et al.
Nature Communications|February 19, 2025
A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer developmentAnne T Schneider, Christiane Koppe, Emilie Crouchet, et al.
Arxiv|March 4, 2025
From FAIR to CURE: Guidelines for Computational Models of Biological SystemsHerbert M Sauro, Eran Agmon, Michael L Blinov, et al.
Pageof 18

Showing results (171-180 of 175) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 175 results.
Translational Oncology|September 1, 2024
Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic responseJingyu An, Roma Kurilov, Teresa Peccerella, et al.
Cancer Cell|April 7, 2015
Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasisSilvia von Karstedt, Annalisa Conti, Max Nobis, et al.
Cancer Discovery|May 27, 2018
<i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic CancerChristoph Heining, Peter Horak, Sebastian Uhrig, et al.
Nature Communications|February 19, 2025
A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer developmentAnne T Schneider, Christiane Koppe, Emilie Crouchet, et al.
Arxiv|March 4, 2025
From FAIR to CURE: Guidelines for Computational Models of Biological SystemsHerbert M Sauro, Eran Agmon, Michael L Blinov, et al.
Pageof 18